Bicycle Therapeutics PLC (BCYC) — DEF 14A Filings
All DEF 14A filings from Bicycle Therapeutics PLC. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Bicycle Therapeutics: Executive Compensation & Equity Awards Detailed
— Apr 23, 2025 Risk: low
Bicycle Therapeutics plc filed a DEF 14A on April 23, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation and equity a -
Bicycle Therapeutics plc Schedules 2024 Annual General Meeting
— Apr 15, 2024 Risk: BCYC
BICYCLE THERAPEUTICS plc (BCYC) filed a Proxy Statement (DEF 14A) with the SEC on April 15, 2024. The 2024 Annual General Meeting (AGM) for Bicycle Therapeutics
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX